Dual-Targeting Nanoplatform to Regulate Metabolic Disorders: From Obesity to Obesity-Related Metabolic Dysfunction-Associated Steatotic Liver Disease

Journal:

Nano Letters

Published:

2025-10-08

DOI:

10.1021/acs.nanolett.5c04561

Affiliations:

7

Authors:

15

Go to article

Institutions	Authors	Share
China Pharmaceutical University (CPU), China	6.000000	0.40
State Key Laboratory of Natural Medicines (SKLNM), CPU, China	5.000000	0.33
University Hospital Bonn (UKB), Uni Bonn, Germany	1.000000	0.07
Leibniz Institute of Polymer Research Dresden (IPF), Germany	1.000000	0.07
Chemnitz University of Technology (TU Chemnitz), Germany	1.000000	0.07
Institute for Experimental Molecular Imaging (ExMI), Germany	1.000000	0.07

Interested in Pharmacology and Pharmaceutical Sciences?